Mike Matson

Stock Analyst at Needham

(0)
# 3444
Out of 5,218 analysts
511
Total ratings
44.16%
Success rate
1.14%
Average return
42 Stocks
Name Action Price Target Current % Upside Ratings Updated
Stryker
Maintains: Strong Buy
409 442
375.05 17.85% 5 Dec 12, 2024
TransMedics Gr
Reiterates: Hold
n/a
n/a n/a 6 Dec 11, 2024
Artivion
Reiterates: Buy
34 34
28.98 17.32% 14 Dec 9, 2024
Haemonetics
Reiterates: Buy
112 112
81.16 38% 10 Dec 3, 2024
Boston Scientific
Reiterates: Hold
n/a
n/a n/a 25 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
75 75
51.57 45.43% 22 Nov 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 14 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
0.78 220.51% 16 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
2.34 81.62% 15 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 4 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
11 13
10.38 25.24% 14 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 21 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 13 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
42 42
22.12 89.87% 19 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 10 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
37 44
43.21 1.83% 14 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
3.84 88.8% 16 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
65 65
46.2 40.69% 11 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 19 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 21 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
17.72 7.22% 21 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 7 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
109 109
102.83 6% 21 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 9 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
97 97
72.53 33.74% 22 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 24 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 15 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
34 40
31.49 27.02% 28 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 9 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 13 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
90 90
73.64 22.22% 15 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 7 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 Nov 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 8
n/a n/a 1 Sep 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
38 39
n/a n/a 8 Jul 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 42
13.37 214.14% 2 May 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 Mar 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 75
82.33 -8.9% 1 Feb 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Jan 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Nov 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
74
n/a n/a 1 Jun 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Mar 13, 2020